2020
DOI: 10.1111/dth.14635
|View full text |Cite
|
Sign up to set email alerts
|

Antimicrobial photodynamic therapy in the treatment of giant molluscum contagiosum: A case report and review of the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
1
1
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 6 publications
(11 reference statements)
0
1
0
Order By: Relevance
“…Newer studies have proposed novel treatment options. Notably, a 2020 case study and literature review [ 2 ] described the effectiveness of photodynamic therapy (2 sessions, 2 weeks apart using 630-nm red light lasting 9 minutes) in association with incubation with 5’-Aminolevulinic acid in completely resolving giant MC (larger than 1 cm in diameter). An alternate review by Wells et al [ 3 ] discussed intralesional immunotherapies in the treatment of MC and highlighted case reports exhibiting resolution rates between 36% and 100% with minimal adverse reactions (erythema, mild edema) with Candida antigen, MMR (measles, mumps, and rubella) vaccine, vitamin D3, and OK- 432 (a penicillin- and heat-treated lyophilized powder of the Streptococcus pyogenes A3 substrain).…”
mentioning
confidence: 99%
“…Newer studies have proposed novel treatment options. Notably, a 2020 case study and literature review [ 2 ] described the effectiveness of photodynamic therapy (2 sessions, 2 weeks apart using 630-nm red light lasting 9 minutes) in association with incubation with 5’-Aminolevulinic acid in completely resolving giant MC (larger than 1 cm in diameter). An alternate review by Wells et al [ 3 ] discussed intralesional immunotherapies in the treatment of MC and highlighted case reports exhibiting resolution rates between 36% and 100% with minimal adverse reactions (erythema, mild edema) with Candida antigen, MMR (measles, mumps, and rubella) vaccine, vitamin D3, and OK- 432 (a penicillin- and heat-treated lyophilized powder of the Streptococcus pyogenes A3 substrain).…”
mentioning
confidence: 99%